132 related articles for article (PubMed ID: 25695373)
1. Expression of integrin-binding protein Nischarin in metastatic breast cancer.
Chen J; Feng WL; Mo WJ; Ding XW; Xie SN
Mol Med Rep; 2015 Jul; 12(1):77-82. PubMed ID: 25695373
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
3. Expression of Nischarin negatively correlates with estrogen receptor and alters apoptosis, migration and invasion in human breast cancer.
Chang C; Wei W; Han D; Meng J; Zhu F; Xiao Y; Wu G; Shi X; Zhang L
Biochem Biophys Res Commun; 2017 Mar; 484(3):536-542. PubMed ID: 28131840
[TBL] [Abstract][Full Text] [Related]
4. Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells.
Maziveyi M; Dong S; Baranwal S; Alahari SK
Mol Cancer; 2018 Feb; 17(1):21. PubMed ID: 29415725
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin.
Maziveyi M; Alahari SK
Cancer Res; 2015 Oct; 75(20):4252-9. PubMed ID: 26392073
[TBL] [Abstract][Full Text] [Related]
6. Nischarin Regulates Secretion of Exosomes and Cancer Progression.
McAndrews KM; Kalluri R
Cancer Res; 2019 May; 79(9):2099-2101. PubMed ID: 31043427
[TBL] [Abstract][Full Text] [Related]
7. Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
Eastlack SC; Dong S; Mo YY; Alahari SK
PLoS One; 2018; 13(6):e0198945. PubMed ID: 29912916
[TBL] [Abstract][Full Text] [Related]
8. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
9. Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.
Jain P; Baranwal S; Dong S; Struckhoff AP; Worthylake RA; Alahari SK
J Biol Chem; 2013 May; 288(22):15495-509. PubMed ID: 23572524
[TBL] [Abstract][Full Text] [Related]
10. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of IRAS/nischarin (I
Keller B; La Harpe R; García-Sevilla JA
Neurochem Int; 2017 Sep; 108():282-286. PubMed ID: 28461172
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
Xiao M; Yang S; Ning X; Huang Y
Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
[TBL] [Abstract][Full Text] [Related]
13. POU5F1/Oct-4 expression in breast cancer tissue is significantly associated with non-sentinel lymph node metastasis.
Cai S; Geng S; Jin F; Liu J; Qu C; Chen B
BMC Cancer; 2016 Mar; 16():175. PubMed ID: 26931354
[TBL] [Abstract][Full Text] [Related]
14. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
[TBL] [Abstract][Full Text] [Related]
15. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
16. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
Kataoka A; Sadanaga N; Mimori K; Ueo H; Barnard GF; Sugimachi K; Auclair D; Chen LB; Mori M
Clin Cancer Res; 2001 Sep; 7(9):2815-20. PubMed ID: 11555598
[TBL] [Abstract][Full Text] [Related]
18. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527
[TBL] [Abstract][Full Text] [Related]
19. The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Cheng CW; Yu JC; Wang HW; Huang CS; Shieh JC; Fu YP; Chang CW; Wu PE; Shen CY
Clin Chim Acta; 2010 Feb; 411(3-4):234-41. PubMed ID: 19914229
[TBL] [Abstract][Full Text] [Related]
20. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
Zhou T; Liu S; Yang L; Ju Y; Li C
J BUON; 2018; 23(3):713-719. PubMed ID: 30003741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
